# Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)

> **NCT03004950** · — · COMPLETED · sponsor: **University of Pittsburgh** · enrollment: 922 (actual)

## Conditions studied

- Acute Renal Failure
- Kidney Diseases
- Chronic Kidney Disease
- Coronary (Artery); Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03004950
- **Lead sponsor:** University of Pittsburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2022-02-28
- **Final completion:** 2023-06-30
- **Target enrollment:** 922 (ACTUAL)
- **Last updated:** 2023-10-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03004950

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03004950, "Biomarker Effectiveness Analysis in Contrast Nephropathy (BEACON)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03004950. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*